Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes

Peter Bressler, Giuseppe Pantaleo, Andrea Demaria, Anthony S. Fauci

Research output: Contribution to journalArticlepeer-review


The CD2 T lymphocyte glycoprotein surface molecule mediates both cell to cell adhesion and T cell activation, two processes that are involved in the spread of HIV infection. Treatment of chronically HIV-infected PBMC with anti-CD2 mAb has been shown to induce the expression of infectious virus from these cultures. In this study we investigated the mechanisms whereby anti-CD2 antibodies stimulate viral production. We demonstrate that treatment of transiently transfected T lymphocytes with anti-CD2 antibodies results in activation of the HIV long terminal repeat. Furthermore, CAT assays using mutated HIV long terminal repeat-CAT constructs and gel shift assays demonstrate that this activation is dependent on the NF-κB enhancer. These studies suggest that interaction of CD2 with its natural ligand, LFA-3, may play a role in regulation of HIV expression.

Original languageEnglish
Pages (from-to)2290-2294
Number of pages5
JournalJournal of Immunology
Issue number7
Publication statusPublished - Oct 1 1991

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes'. Together they form a unique fingerprint.

Cite this